Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy
Prz Menopauzalny. 2023 Jun;22(2):117-119.
doi: 10.5114/pm.2023.128815.
Epub 2023 Jun 2.